Xiao Qin Lu
Director/Board Member at FORTRESS BIOTECH, INC.
Net worth: 32 309 $ as of 29/04/2024
Network origin in Xiao Qin Lu first degree
Entity | Entity type | Industry | |
---|---|---|---|
Lazard Asset Management LLC
Lazard Asset Management LLC Investment ManagersFinance Lazard Asset Management LLC (LAM) is a SEC-registered investment advisor headquartered in New York City. The firm was founded in 1970 and is a wholly-owned subsidiary of Lazard Frères & Co. LLC, ultimately held by Lazard Ltd. (NYSE: LAZ). LAM provides investment advisory services to a variety of clients.
71
| Subsidiary | Investment Managers | 71 |
29
| Public Company | Pharmaceuticals: Major | 29 |
Public Company | Pharmaceuticals: Major | 25 | |
19
| Public Company | Biotechnology | 19 |
Public Company | Pharmaceuticals: Major | 15 | |
Inventia Healthcare Ltd.
Inventia Healthcare Ltd. Pharmaceuticals: MajorHealth Technology Inventia Healthcare Ltd. engages in the development and manufacture of pharmaceutical formulations. It caters anti-diabetic, gastrointestinal, CVC, CNS and musculoskeletal therapeutic areas. The company was founded by Janak Shah and Maya Shah in 1985 and is headquartered in Mumbai, India.
15
| Holding Company | Pharmaceuticals: Major | 15 |
Lehman Brothers Global Asset Management
Lehman Brothers Global Asset Management Investment Banks/BrokersFinance Part of Franklin Resources, Inc., Lehman Brothers Global Asset Management is an American asset management company. The private company is based in NY. Lehman Brothers Global Asset Management was acquired by Legg Mason, Inc., a subsidiary of Franklin Resources, Inc. from Lehman Brothers Holdings, Inc. on February 13, 1996 for $10 million.
4
| Subsidiary | Investment Banks/Brokers | 4 |
Public Company | Pharmaceuticals: Major | 3 | |
Innovative Cellular Therapeutics, Inc.
2
| Private Company | 2 | |
Innovative Cellular Therapeutics Co., Ltd.
Innovative Cellular Therapeutics Co., Ltd. BiotechnologyHealth Technology Innovative Cellular Therapeutics Co., Ltd. is a Chinese private clinical stage biotechnology company headquartered in an undisclosed location. Innovative Cellular Therapeutics is focused on the development of cellular immunotherapies for the treatment of solid tumors, using their unique CoupledCAR® technology platform. The company has achieved promising preclinical and proof-of-concept clinical results in late-stage solid tumors, such as colorectal cancer and prostate cancer, and has a broad pipeline of CAR-T candidates targeting additional solid tumors. The company was founded in 2009 by Zhao Wu and Lei Xiao, with Lei Xiao serving as the CEO since then.
2
| Holding Company | Biotechnology | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Xiao Qin Lu via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
TG THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder Chief Executive Officer Director/Board Member Director/Board Member Director/Board Member | |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
University of Mumbai | College/University | Undergraduate Degree Graduate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree Graduate Degree | |
The Trustees of Columbia University in The City of New York | College/University | Corporate Officer/Principal Graduate Degree Masters Business Admin Doctorate Degree Undergraduate Degree | |
New York University | College/University | Undergraduate Degree Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
Caelum Biosciences, Inc.
Caelum Biosciences, Inc. BiotechnologyHealth Technology Caelum Biosciences, Inc. operates as a clinical-stage biotechnology company developing treatments for rare and life-threatening diseases. The company was founded in January 2017 and is headquartered in New York, NY. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Laboratoires Fournier SAS
Laboratoires Fournier SAS Pharmaceuticals: MajorHealth Technology Laboratoires Fournier SAS manufactures pharmaceutical preparations. The company was founded on July 10, 2007 and is headquartered in Rungis, France. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
University of Pennsylvania | College/University | Graduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree | |
ORIGO ACQUISITION CORP | Financial Conglomerates | Chief Executive Officer Chairman Director/Board Member Chief Operating Officer | |
MUSTANG BIO, INC. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member Director of Finance/CFO | |
Council on Foreign Relations, Inc.
Council on Foreign Relations, Inc. Investment Trusts/Mutual FundsMiscellaneous Council on Foreign Relations, Inc. provides and disseminates ideas on foreign policies to individuals, corporate members, journalists and policy makers. It operates a forum for government officials, students and other interested parties to study and discuss world issues and impact on American foreign policies. The company publishes Foreign Affairs, a magazine that comes out six times a year, along with books and studies by its own scholars. Council on Foreign Relations was founded in 1921 and is headquartered in New York City, NY. | Investment Trusts/Mutual Funds | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
JOURNEY MEDICAL CORPORATION | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
University of Delhi | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
KERYX BIOPHARMACEUTICALS | Pharmaceuticals: Major | Founder Chief Executive Officer Director/Board Member | |
LAZARD, INC. | Investment Banks/Brokers | Director/Board Member Corporate Officer/Principal | |
Gujarat University | College/University | Undergraduate Degree Undergraduate Degree | |
Yeshiva University | College/University | Undergraduate Degree Undergraduate Degree | |
OPKO HEALTH, INC. | Medical/Nursing Services | Corporate Officer/Principal Corporate Officer/Principal | |
The University of Chicago | College/University | Masters Business Admin Masters Business Admin | |
Vanderbilt University School of Medicine | College/University | Corporate Officer/Principal Doctorate Degree | |
LAZARD GLOBAL TOTAL RETURN AND INCOME FUND, INC. | Investment Trusts/Mutual Funds | Director/Board Member Investor Relations Contact | |
Pace University | College/University | Masters Business Admin Undergraduate Degree | |
Ferring Pharmaceuticals, Inc.
Ferring Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals, Inc. develops and markets fertility and endocrinology products. Its products include Bravelle, Repronex, Novarel, Acthrel and Desmopressin Acetate. The company's products are used in treatment of osteoarthritis, prostate cancer, and other infertility related diseases. Ferring Pharmaceuticals was founded in 1951 and is headquartered in Parsippany, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Undergraduate Degree | |
Massachusetts Institute of Technology | College/University | Graduate Degree Doctorate Degree | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
Hofstra University | College/University | Undergraduate Degree Undergraduate Degree | |
The Johns Hopkins University School of Medicine | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
University of Iowa | College/University | Doctorate Degree Graduate Degree | |
Multi Commodity Exchange Clearing Corp. Ltd.
Multi Commodity Exchange Clearing Corp. Ltd. Finance/Rental/LeasingFinance Multi Commodity Exchange Clearing Corp. Ltd. operates as a clearing corporation. It provides clearing and settlement services Multi Commodity Exchange of India Ltd. The firm collects margin from the members, effect pay-in and pay-out and oversee delivery and settlement process. The company was founded on August 1, 2008 and is headquartered in Mumbai, India. | Finance/Rental/Leasing | Chairman Director/Board Member | |
The Johns Hopkins University | College/University | Corporate Officer/Principal Graduate Degree | |
The Institute of Chartered Accountants of India | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
AI Proteins, Inc.
AI Proteins, Inc. Pharmaceuticals: MajorHealth Technology AI Proteins, Inc. is a biotech company based in Andover, MA. AI Proteins is focused on re-imagining protein therapeutics by designing entirely new proteins using an AI-based approach and a high-throughput drug discovery platform. The company's platform enables the development of inexpensive, durable, and highly specific proteins optimized for specific therapeutic applications. These proteins have the potential for oral delivery and can dramatically accelerate the development of lead therapeutic candidates ready for IND-enabling studies. The company was founded by Marc A. Cohen and Christopher Bahl. Noah D. Beerman has been the CEO of the company since 2023. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Université Paris Dauphine-PSL | College/University | Undergraduate Degree Graduate Degree | |
Yale University | College/University | Doctorate Degree Undergraduate Degree |
Statistics
International
United States | 34 |
India | 7 |
France | 3 |
Germany | 2 |
Mexico | 2 |
Sectoral
Consumer Services | 21 |
Health Technology | 14 |
Finance | 7 |
Miscellaneous | 3 |
Commercial Services | 2 |
Operational
Director/Board Member | 298 |
Corporate Officer/Principal | 196 |
Independent Dir/Board Member | 80 |
Undergraduate Degree | 78 |
Chief Executive Officer | 54 |
Most connected contacts
Insiders | |
---|---|
Chris Buyse | 39 |
Eric Rowinsky | 36 |
Bobby Sandage | 29 |
Ved Kumar Jain | 29 |
Malcolm Hoenlein | 28 |
J. Lobell | 27 |
Michael Weiss | 25 |
Nagesh Dinkar Pinge | 23 |
Lindsay Rosenwald | 23 |
Neil Herskowitz | 22 |
Ashish Bhutani | 20 |
Harlan Weisman | 20 |
Jay Kranzler | 15 |
Christopher Gregory Newton | 15 |
David Francis K. Finlay | 14 |
- Stock Market
- Insiders
- Xiao Qin Lu
- Company connections